Clinical Trials Logo

Clinical Trial Summary

This study retrospectively evaluates clinical parameters and outcome of patients with advanced stage non-small cell lung cancer treated with neoadjuvant therapy followed by curative-intent surgery at the Divison of Thoracic Surgery at the Medical University of Vienna


Clinical Trial Description

This study will be undertaken as a retrospective cohort study at Devision of Thoracic Surgery, Medical University of Vienna. All patients with non-small-cell lung cancer, who received an induction chemo- or chemoradiotherapy followed by surgery in a curative intention at the Devision of Thoracic Surgery, Medical University, will be included. The aim of this study is to evaluate peri- and postoperative clinical parameters and short- and long-term outcomes in patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04455984
Study type Observational
Source Medical University of Vienna
Contact Katharina Sinn, MD
Phone 004314040056440
Email katharina.sinn@meduniwien.ac.at
Status Recruiting
Phase
Start date May 1, 2017
Completion date August 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05435274 - Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer Phase 1/Phase 2
Enrolling by invitation NCT05192681 - Tislelizumab as Cross-line Treatment for Advanced NSCLC Phase 2
Active, not recruiting NCT05499390 - AK112 in Advanced Non-Small Cell Lung Cancer Phase 3
Not yet recruiting NCT04733521 - A Phase 1/2 Study of SC-43 in Combination With Cisplatin Phase 1/Phase 2
Completed NCT05380908 - Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer
Recruiting NCT05904379 - AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer Phase 1/Phase 2